REFERENCES
- J. C. Guyonnet and L. Julou, Rheumatology and Rehabilitation (Suppl.), 11. (1975).
- B. Fjalland, J. Pharm. Pharmacol., 28, 683 (1976).
- Y. Suzuki, M. Ito and I. Vagami, Jap. J. Pharmacol., 26, 91 (1976).
- Y. Mizushima, V. Ishii, and S. Masumoto, Biochem. Pharmacol., 24., (1975).
- “Martindale, The Extra Pharmacopoeia,” 28th Ed., Pharmaceutical Press, London, 1982, p. 264.
- R. Runkel, E. Forchielli, G. Boost, M. Chaplin, R. Hill, H. Sevelius, G. Thompson and E. Segre, Scand. J. Rheum. (Suppl. 2) 29 (1973).
- H. F. Hill, A. G. S. Hill, J. M. Gumpel, A. G. Mowat, B. M. Ansel, D. I. Haslock and J. A. Mathews, “Naprosyn in open study in patients intolerant of other non-steroidal anti-inflammatory agents, Naprosyn in the treatment of Rheumatic diseases, “Proceedings of a Symposium,” London (Syntex, Maidenhead), 1973, p. 47.
- S. Cobb, “The Frequency of the Rheumatic Diseases,” Harvard University Press, Cambridge, Mass., 1971, p, 40.
- J. L. Hollander, “Arthritis and Allied Conditions,” J. L. Hollander and D. J. McCarthy, Eds., Lea and Febiger
- Health Statistics, Series B, No. 36, U. S. Department of Health Education and Welfare, Washington, 1962, p. 14.
- Warren A. Katz, “Rheumatic Diseases, Diagnosis and Management,” J. B. Lippincott Co., Philadelphia, 1977, p. 390.
- A. G. Mowat, B. M. Ansel, J. M. Gumpel, H. F. H. Hill, A. G. S. Hill and M. Stoppard, Ann. Rheu. Pis., 35, 498 (1976).
- S. H. Roth and G. Boost, J. Clin. Pharmacol., 15., 378 (1975).
- P. Grasso and A. B. G. Lansdown, J. Soc. Cosmet. Chem., 23, 481 (1972).
- A. Mark. hu, J. Pharm. Sci., 66, 433 (1977).
- M. Broquaire, V. Rovei and R. Braithwaite, J. Chromatoqr., Biomedical Applications, 224, 43 (1981).
- T. Higuchi, J. Soc. Cosm. Chem. 11, 85 (1960).
- T. Higuchi, J. Pharm. Sci., 50., 874 (1961).
- T. Higuchi, J. H. Richards, S. S. Davies, A. Kamada, J. P. Hou, M. Nakamo, N. I. Nakamo and I. H. Pitman, J. Pharm, Sci., 58., 661 (1969).
- N. H. Creasy, J. Battensby and J. A. Fletcher, Curr? Probl? Dermatol., 7, 95 (1978).
- S. Niazi, “Textbook of Biopharmaceuti. es and Clinical Pharmacokinetics,” Appleton-Century-Crofts, NY, 1979.
- R. N. Brogen, R. C. Heel, T. M. Speight and G. S. Avery, Drugs, 18., 241 (1979).
- A. L. Allenby, J. Fletcher, C. Schock and T. F. S. Tees, Brit, it. Dermatol., (Suppl. 4), 81., 31 (1969).
- C. B. Barrett, J. W. Hadgraft, G. A. Caron and I. Sarkany, Brit. J. Dermatol., 77., 576 (1965).